XSpray Pharma AB (publ) - ESG Rating & Company Profile powered by AI
This webpage of XSpray Pharma AB (publ) was prepared by All Street Sevva using proprietary AI. Alternative companies in the rating peer group for XSpray Pharma AB (publ) are shown. If you work at XSpray Pharma AB (publ) and you wish to licence your ESG rating, please get in touch.
XSpray Pharma AB (publ) in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.8; made up of an environmental score of 2.7, social score of 4.8 and governance score of 4.0.
3.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1089 | Zymeworks Inc | 3.9 | Medium |
| 1089 | bluebird bio Inc | 3.9 | Medium |
| 1112 | XSpray Pharma AB (publ) | 3.8 | Medium |
| 1112 | AcelRx Pharmaceuticals Inc | 3.8 | Medium |
| 1112 | Arcus Biosciences Inc | 3.8 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does XSpray Pharma AB (publ) have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose current and historical energy intensity?
Sign up for free to unlockDoes XSpray Pharma AB (publ) report the average age of the workforce?
Sign up for free to unlockDoes XSpray Pharma AB (publ) reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose its ethnicity pay gap?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose cybersecurity risks?
Sign up for free to unlockDoes XSpray Pharma AB (publ) offer flexible work?
Sign up for free to unlockDoes XSpray Pharma AB (publ) have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose the number of employees in R&D functions?
Sign up for free to unlockDoes XSpray Pharma AB (publ) conduct supply chain audits?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes XSpray Pharma AB (publ) conduct 360 degree staff reviews?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose the individual responsible for D&I?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose water use targets?
Sign up for free to unlockDoes XSpray Pharma AB (publ) have careers partnerships with academic institutions?
Sign up for free to unlockDid XSpray Pharma AB (publ) have a product recall in the last two years?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose incidents of discrimination?
Sign up for free to unlockDoes XSpray Pharma AB (publ) allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas XSpray Pharma AB (publ) issued a profit warning in the past 24 months?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose parental leave metrics?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose the pay ratio of women to men?
Sign up for free to unlockDoes XSpray Pharma AB (publ) support suppliers with sustainability related research and development?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes XSpray Pharma AB (publ) reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs XSpray Pharma AB (publ) involved in embryonic stem cell research?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose its waste policy?
Sign up for free to unlockDoes XSpray Pharma AB (publ) report according to TCFD requirements?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose energy use targets?
Sign up for free to unlockDoes XSpray Pharma AB (publ) disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes XSpray Pharma AB (publ) have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for XSpray Pharma AB (publ)
These potential risks are based on the size, segment and geographies of the company.
Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include HyNap-Nilo, HyNap-Sora, and HyNap-Dasa. The company was formerly known as Xspray Microparticles AB and changed its name to Xspray Pharma AB (publ) in 2017. Xspray Pharma AB (publ) was incorporated in 2003 and is headquartered in Solna, Sweden.